Cargando…
Effects of a remote patient monitoring system for patients on automated peritoneal dialysis: a randomized crossover controlled trial
PURPOSE: Remote patient monitoring (RPM) has contributed to improved patient-centered outcomes and prognosis in patients with end-stage renal disease on automated peritoneal dialysis (APD). However, evidence from prospective trials is lacking. METHODS: The participants (n = 15; median age: 65 years;...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972739/ https://www.ncbi.nlm.nih.gov/pubmed/35362819 http://dx.doi.org/10.1007/s11255-022-03178-5 |
_version_ | 1784679912171372544 |
---|---|
author | Uchiyama, Kiyotaka Morimoto, Kohkichi Washida, Naoki Kusahana, Ei Nakayama, Takashin Itoh, Tomoaki Kasai, Takahiro Wakino, Shu Itoh, Hiroshi |
author_facet | Uchiyama, Kiyotaka Morimoto, Kohkichi Washida, Naoki Kusahana, Ei Nakayama, Takashin Itoh, Tomoaki Kasai, Takahiro Wakino, Shu Itoh, Hiroshi |
author_sort | Uchiyama, Kiyotaka |
collection | PubMed |
description | PURPOSE: Remote patient monitoring (RPM) has contributed to improved patient-centered outcomes and prognosis in patients with end-stage renal disease on automated peritoneal dialysis (APD). However, evidence from prospective trials is lacking. METHODS: The participants (n = 15; median age: 65 years; males: 10; peritoneal dialysis vintage: 6.4 ± 3.5 years) randomly received APD therapy using the Kaguya® APD system either with or without the connective use of the cloud-based RPM software Sharesource® for 12 weeks. The primary outcome was patient satisfaction assessed using a modified nine-item Treatment Satisfaction Questionnaire for Medication (TSQM-9) questionnaire. The secondary outcomes were healthcare resource consumption, the health-related quality of life (HRQOL) subscales assessed with the Kidney Disease Quality of Life-Short Form questionnaire, and clinical laboratory parameters. RESULTS: Significant improvements were observed in the TSQM-9 subscales of Effectiveness (64.4 ± 18.8 vs. 57.8 ± 18.8; P = 0.006) and Convenience (76.3 ± 15.4 vs. 63.3 ± 17.3; P < 0.001) in patients on Sharesource®. Moreover, Sharesource® reduced the total amount of healthcare resource consumption (0.80 ± 1.32 vs. 1.87 ± 2.39 times/12 weeks; P = 0.02) and consultation time during regular monthly visits (813 ± 269 vs. 1024 ± 292 s; P < 0.001). A significant increase in ultrafiltration volume was found associated with more frequent modification of APD prescription in patients with Sharesource®. Sharesource® also improved the HRQOL subscale of General Health and Vitality. CONCLUSION: Sharesource® can improve patient-centered outcomes in patients on APD while reducing the treatment burden for both patients and medical staff. Trial registration: The study was registered in the Japan Registry of Clinical Trials (jRCT Number: jRCTs032190005). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11255-022-03178-5. |
format | Online Article Text |
id | pubmed-8972739 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Netherlands |
record_format | MEDLINE/PubMed |
spelling | pubmed-89727392022-04-01 Effects of a remote patient monitoring system for patients on automated peritoneal dialysis: a randomized crossover controlled trial Uchiyama, Kiyotaka Morimoto, Kohkichi Washida, Naoki Kusahana, Ei Nakayama, Takashin Itoh, Tomoaki Kasai, Takahiro Wakino, Shu Itoh, Hiroshi Int Urol Nephrol Nephrology - Original Paper PURPOSE: Remote patient monitoring (RPM) has contributed to improved patient-centered outcomes and prognosis in patients with end-stage renal disease on automated peritoneal dialysis (APD). However, evidence from prospective trials is lacking. METHODS: The participants (n = 15; median age: 65 years; males: 10; peritoneal dialysis vintage: 6.4 ± 3.5 years) randomly received APD therapy using the Kaguya® APD system either with or without the connective use of the cloud-based RPM software Sharesource® for 12 weeks. The primary outcome was patient satisfaction assessed using a modified nine-item Treatment Satisfaction Questionnaire for Medication (TSQM-9) questionnaire. The secondary outcomes were healthcare resource consumption, the health-related quality of life (HRQOL) subscales assessed with the Kidney Disease Quality of Life-Short Form questionnaire, and clinical laboratory parameters. RESULTS: Significant improvements were observed in the TSQM-9 subscales of Effectiveness (64.4 ± 18.8 vs. 57.8 ± 18.8; P = 0.006) and Convenience (76.3 ± 15.4 vs. 63.3 ± 17.3; P < 0.001) in patients on Sharesource®. Moreover, Sharesource® reduced the total amount of healthcare resource consumption (0.80 ± 1.32 vs. 1.87 ± 2.39 times/12 weeks; P = 0.02) and consultation time during regular monthly visits (813 ± 269 vs. 1024 ± 292 s; P < 0.001). A significant increase in ultrafiltration volume was found associated with more frequent modification of APD prescription in patients with Sharesource®. Sharesource® also improved the HRQOL subscale of General Health and Vitality. CONCLUSION: Sharesource® can improve patient-centered outcomes in patients on APD while reducing the treatment burden for both patients and medical staff. Trial registration: The study was registered in the Japan Registry of Clinical Trials (jRCT Number: jRCTs032190005). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11255-022-03178-5. Springer Netherlands 2022-04-01 2022 /pmc/articles/PMC8972739/ /pubmed/35362819 http://dx.doi.org/10.1007/s11255-022-03178-5 Text en © The Author(s), under exclusive licence to Springer Nature B.V. 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Nephrology - Original Paper Uchiyama, Kiyotaka Morimoto, Kohkichi Washida, Naoki Kusahana, Ei Nakayama, Takashin Itoh, Tomoaki Kasai, Takahiro Wakino, Shu Itoh, Hiroshi Effects of a remote patient monitoring system for patients on automated peritoneal dialysis: a randomized crossover controlled trial |
title | Effects of a remote patient monitoring system for patients on automated peritoneal dialysis: a randomized crossover controlled trial |
title_full | Effects of a remote patient monitoring system for patients on automated peritoneal dialysis: a randomized crossover controlled trial |
title_fullStr | Effects of a remote patient monitoring system for patients on automated peritoneal dialysis: a randomized crossover controlled trial |
title_full_unstemmed | Effects of a remote patient monitoring system for patients on automated peritoneal dialysis: a randomized crossover controlled trial |
title_short | Effects of a remote patient monitoring system for patients on automated peritoneal dialysis: a randomized crossover controlled trial |
title_sort | effects of a remote patient monitoring system for patients on automated peritoneal dialysis: a randomized crossover controlled trial |
topic | Nephrology - Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972739/ https://www.ncbi.nlm.nih.gov/pubmed/35362819 http://dx.doi.org/10.1007/s11255-022-03178-5 |
work_keys_str_mv | AT uchiyamakiyotaka effectsofaremotepatientmonitoringsystemforpatientsonautomatedperitonealdialysisarandomizedcrossovercontrolledtrial AT morimotokohkichi effectsofaremotepatientmonitoringsystemforpatientsonautomatedperitonealdialysisarandomizedcrossovercontrolledtrial AT washidanaoki effectsofaremotepatientmonitoringsystemforpatientsonautomatedperitonealdialysisarandomizedcrossovercontrolledtrial AT kusahanaei effectsofaremotepatientmonitoringsystemforpatientsonautomatedperitonealdialysisarandomizedcrossovercontrolledtrial AT nakayamatakashin effectsofaremotepatientmonitoringsystemforpatientsonautomatedperitonealdialysisarandomizedcrossovercontrolledtrial AT itohtomoaki effectsofaremotepatientmonitoringsystemforpatientsonautomatedperitonealdialysisarandomizedcrossovercontrolledtrial AT kasaitakahiro effectsofaremotepatientmonitoringsystemforpatientsonautomatedperitonealdialysisarandomizedcrossovercontrolledtrial AT wakinoshu effectsofaremotepatientmonitoringsystemforpatientsonautomatedperitonealdialysisarandomizedcrossovercontrolledtrial AT itohhiroshi effectsofaremotepatientmonitoringsystemforpatientsonautomatedperitonealdialysisarandomizedcrossovercontrolledtrial |